Cargando…
MicroRNA 132-3p Is Upregulated in Laron Syndrome Patients and Controls Longevity Gene Expression
The growth hormone (GH)–insulin-like growth factor-1 (IGF1) endocrine axis is a central player in normal growth and metabolism as well as in a number of pathologies, including cancer. The GH–IGF1 hormonal system, in addition, has emerged as a major determinant of lifespan and healthspan. Laron syndr...
Autores principales: | Yaron-Saminsky, Danielle, Nagaraj, Karthik, Sarfstein, Rive, Laron, Zvi, Pasmanik-Chor, Metsada, Werner, Haim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584665/ https://www.ncbi.nlm.nih.gov/pubmed/34769292 http://dx.doi.org/10.3390/ijms222111861 |
Ejemplares similares
-
Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways
por: Werner, Haim, et al.
Publicado: (2019) -
Laron Syndrome Research Paves the Way for New Insights in Oncological Investigation
por: Werner, Haim, et al.
Publicado: (2020) -
Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action
por: Aizen, Daniel, et al.
Publicado: (2018) -
Long-Term IGF1 Stimulation Leads to Cellular Senescence via Functional Interaction with the Thioredoxin-Interacting Protein, TXNIP
por: Nagaraj, Karthik, et al.
Publicado: (2022) -
Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns
por: Sarfstein, Rive, et al.
Publicado: (2020)